Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-29 14:00:18 - browse：98324

Silhouette of a medical staff, followed by another, running pushing a nursing bed. Two people talk next to the hurrying staff in the corridor — coverage from STAT — Adobe

There’s ample evidence that private equity buyouts in health care drive up costs. A new study shows quality declines, too.

Hospitals acquired by private equity saw a 25% uptick in adverse events compared with controls, according to a new study released today in the Journal of the American Medical Association. The findings add to an accumulating body of literature underscoring the harm that occurs when financial investors take over health care providers — not only hospitals, but nursing homes, hospice care, and physician practices.

Even after adjusting their findings to be more conservative, the researchers on the JAMA study found that all of the hospital-acquired conditions they studied increased three years after a private equity acquisition compared to control hospitals. Not all of the increases were statistically significant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： How to fix the rural physician shortage in the U.S.

WSS

Obesity now affects over 1 billion people worldwide, study finds

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Emergency medicine has repudiated 'excited delirium.' Now what?

RSV vaccines may be linked to small increased risk of developing GBS

Why getting cancer drugs just got harder for rural patients

RaDonda Vaught to speak at CommonSpirit event on patient safety

hotspot

Wikipedia

knowledge

After affirmative action ruling, medical educators look to 'holistic review'

Scientists unlock the key to scar

As demand for Covid shots wanes, Moderna seeks its next success

Clinical trials giant ICON acquires HumanFirst

Guidelines to prevent youth baseball injuries need more muscle

Why Sanofi got shellacked over its spinoff

Moonlake's readout produced a cash windfall. Risks remain

In search for therapies for solid tumors, companies turn to claudin

Medicare proposal to cover medical devices draws a mixed reaction

International team creates first chimeric human

focus

Biotech companies concerned about China biosecurity crackdown

Telehealth options flood the market as retailers push virtual care

Change Healthcare cyberattack outage could last weeks

Cassava reveals details — and problems — with Alzheimer's study

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Testing for cancer recurrence creates a new limbo for patients

explore

explore

Wikipedia

hotspot